FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/28/2026
Back to search
Official data from USPTO
CTGCT CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079404288Class
1, 5, 9, 10, 16, 25, 41, 42
Filing
79404288
Registration
8007020
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/29/2026
Trademark type
Combined
Nice classes
1, 5, 9, 10, 16, 25, 41, 42
Filing date
04/30/2024
Registration date
11/04/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/04/2025
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
SI
Examiner
LEE, YATSYE ISADORA
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of two adjacent, slightly offset quadrilaterals outlined in blue, displaying the letters "CTGCT" in blue upon a white background, all of which appears above the wording "CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY" in blue.
Holders and representatives
Holders
Kemijski institut
Representatives
Jennifer Fraser Dykema Gossett PLLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 16Class 25Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in science; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; chemical materialsnamely assaysreagentsnucleic acids for use in gene and cell therapy research; Chemical preparations for scientific purposes; natural fertilisers; chemical products used in gene and cell therapy technologiesnamely viral vectorsplasmidslipid nanoparticles for gene delivery; active chemical ingredients used in the manufacture of medicines for diseases and cancer
Class 5
Pharmaceuticals and medical preparations for the treatment of genetic diseasesneurodevelopmental diseases and cancers; Diagnostic preparations for medical purposes; cells for medical use; pharmaceutical and medical preparations used in gene and cell therapy technologies; pharmaceutical compoundspreparationsmedicines used in the treatment of genetic diseasesneurodevelopmental diseasescancers; pharmaceutical compoundspreparationsmedicines used in the treatment of genetic diseases and cancer
Class 9
Scientificresearchteaching and detecting apparatus and instrumentsmicroscopesconfocal laser microscopesflow cytometersbioreactors for cell culturingcell sortersanalytical systems composed of microscopesspectrophotometersluminometersspectrofluorimeterscomputer hardware for analyzing cells; downloadable computer software for analyzing biological datadesigning gene and cell therapiesmanaging laboratory processes in the field of gene and cell therapy; scientific apparatus and instrumentsmicroscopesconfocal laser microscopesflow cytometersbioreactors for cell culturingdownloadable computer software for analyzing cell populationsdesigning viral vectorsoptimizing bioreactor processes used in gene and cell therapy technologies; scientific apparatus and instrumentshigh-throughput confocal microscopes for kinetics measurements and in vivo imaging systems composed of micro CTmagnetic resonance imaging apparatusnot for medical purposesfor live animal imaging in gene and cell therapy researchdownloadable computer software for analyzing genetic sequences and modeling drug responses used in the treatment of diseases and cancer; Prerecorded USB flash drives featuring educational content on gene and cell therapy technologies and their applications in treating diseases and cancer
Class 10
Surgical and medical apparatus and instruments for use in gene therapy and cell therapy; surgical and medical apparatus and instruments used during medical and surgical procedures; medical apparatuses and instrumentsbioreactorscell sortersflow cytometersanalytical systems composed of medical imaging apparatuses all of which provide cell and particle analysisdetectioncounting for medicalmedical diagnostictherapeutic uses in the field of gene and cell therapy technologies; medical devices used in the treatment of genetic diseases and cancers
Class 16
Printed matterprinted brochuresreportseducational materials in the field of gene and cell therapyadvanced therapy medicinal products (ATMPs)translational medicine; bookbinding tape; printed photographs; stationery and office requisitesprinted notepads; printed notebooks; printed journals related to gene and cell therapy technology; printed informational flyers related to the treatment of diseases and cancer
Class 25
Clothinglab coatspantsshirtst-shirts and headwear
Class 41
Educationconferencesworkshopsseminarsonline courses in the field of gene and cell therapyadvanced therapy medicinal products (ATMPs)translational medicine and distribution of course material in connection therewith; publication of textsproviding online non-downloadable news articles in the field of gene and cell therapyATMPstranslational medicinewriting of textswriting of articles for professional journals other than for advertising or publicity; audiovideomultimedia productionas well as photography; educational and teaching servicesworkshopsseminarsconferencesonline courseshands-on training in the field of gene and cell therapyATMPstranslational medicine; organizing conferencesexhibitionscompetitions in the field of gene and cell therapyATMPstranslational medicine; educationconferencesworkshopsseminarsonline courses in the field of gene and cell therapy technology; educationworkshopsseminarstraining programs in the treatment of diseases and cancer
Class 42
Scientific and technological servicesresearch and design in the fields of treatments for genetic diseasesneurodevelopmental diseases and cancersgene and cell therapy technology; industrial analysisindustrial research and industrial design services in the fields of treatments for genetic diseasesneurodevelopmental diseases and cancersgene and cell therapy technology; quality control and authentication services in the field of gene and cell therapy products; design and development of computer hardware and software; scientific laboratory services; biological and medical research laboratory services; laboratory servicesrental of laboratory apparatus and instruments; Research laboratory analysis services in the field of gene therapycell therapysynthetic biology; biological researchclinical research in the field of gene therapy and cell therapy for genetic diseasesneurodevelopmental diseases and difficult-to-treat cancersmedical research; design and development of medical technology; development of new technologies for others in the field of gene and cell therapies; design and development of gene and cell therapy technology; scientific research for medical purposes in the field of diseases and cancer
Publications
History of USPTO decisions and trademark events.
30 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/12/2026
FIMP
FINAL DISPOSITION PROCESSED
05/12/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/26/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/11/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/11/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/16/2025
PUBO
PUBLISHED FOR OPPOSITION
09/16/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/13/2025
RFNP
REFUSAL PROCESSED BY IB
07/19/2025
CNRT
NON-FINAL ACTION WRITTEN
06/23/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/13/2025
RFNT
REFUSAL PROCESSED BY IB
12/21/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/02/2024
RFRR
REFUSAL PROCESSED BY MPU
12/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/16/2024
CNRT
NON-FINAL ACTION WRITTEN
11/15/2024
DOCK
ASSIGNED TO EXAMINER
11/14/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/12/2024
Continuous trademark protection
Get notified about every new filing that threatens CTGCT CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.